Tall-oil fatty acids salts of condensation products of tall-oil fatty acids with diethanolamine and triethanolamine

Acute Toxicity: oral

Administrative data

Endpoint:

acute toxicity: oral

Type of information:

migrated information: read-across from supporting substance (structural analogue or surrogate)

Adequacy of study:

key study

Reliability:

2 (reliable with restrictions)

Rationale for reliability incl. deficiencies:

other: Read-across from GLP-compliant guideline study performed with similar substance.

Data source

Reference

Reference Type:

study report

Title:

Unnamed

Year:

2001

Report date:

2001

Materials and methods

Test guideline

Test guideline 1

Qualifier:

according to guideline

Guideline:

EU Method B.1 tris (Acute Oral Toxicity - Acute Toxic Class Method)

Version / remarks:

of 1996

Deviations:

no

Test guideline 2

Qualifier:

according to guideline

Guideline:

OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)

Version / remarks:

of 1996

Deviations:

no

GLP compliance:

yes

Test type:

acute toxic class method

Limit test:

yes

Test material

Test material information

Constituent 1

Test animals

Species:

rat

Strain:

Wistar

Sex:

male/female

Details on test animals or test system and environmental conditions:

TEST ANIMALS
- Wistar rats, strain: Crl:(WI) BR (outbred, SPF-Quality) with appropriate range of bodyweight at study start.
Females were nulliparous and non-pregnant.
- Source: Charles River Deutschland, Sulzfeld, Germany.
- Age at study initiation (day of dosing): Approx. 7 weeks.
- Weight at study initiation (day of dosing): Males: mean: 255 g, minimum 252 g, maximum 260 g
Females: mean: 177 g, minimum 170 g, maximum 181 g.
- Fasting period: Overnight (for a maximum of 20 hours) prior to dosing until 3-4 hours post administration.
Water was available.
- Housing: Group housing with 3 animals/Macrolon type IV cage.
- Diet (ad libitum): Commercially available standard pelleted laboratory animal diet (from Altromin, code VRF 1).
- Water (ad libitum): Tap water
- Acclimation period: At least 5 days before start of dosing under laboratory conditions.


ENVIRONMENTAL CONDITIONS

Animals were housed in a controlled environment with optimal conditions considered to be approximately 15 air changes per hour, 21±3°C, 30-70% relative humidity, and 12 hours artificial fluorescent light and 12 hours darkness per day.

Administration / exposure

Route of administration:

oral: gavage

Vehicle:

unchanged (no vehicle)

Details on oral exposure:

DOSE VOLUME APPLIED:

A dose volume of 1.68 mL unchanged test substance per kg bodyweight was administered by oral gavage. In view of a specific gravity of 1.19, the administered dose volume corresponds to a dose of 2000 mg unchanged test substance per kg body weight.

CLASS METHOD - Rationale for the selection of the starting dose:
Starting at the limit dose of 2000 mg/kg, in retrospect, proved to be appropriate, as no animals died at this dose.

Doses:

2000 mg/kg bw (3 males + 3 females)

No. of animals per sex per dose:

3

Control animals:

no

Details on study design:

Post-dosing observation period was 14 days during which mortality/survival and clinical signs were recorded at: 0, 2 and 4 hours after dosing on day 1 and twice daily (mortality/survival) or once daily (clinical signs) thereafter until day 15. Body weight of each animal was recorded on day 1 (prior to dosing) and on days 8 and 15. At the end of the 14-day post-dosing observation period (day 15), all animals were killed by asphyxiation with oxygen/carbon dioxide and necropsied. Macroscopic pathology findings were recorded.

Statistics:

Not applicable, as there were no deaths and only one dose group. In addion, the acute toxic class method is not intended for the calculation of a precise LD50 value.

Results and discussion

Effect levels

Sex:

male/female

Dose descriptor:

LD50

Effect level:

> 2 000 mg/kg bw

Remarks on result:

other: No deaths at the limit dose of 2000 mg/kg

Mortality:

Dose level Mortality Date of treatment
2000 mg/kg 0/3 (f) 09 January 2001
2000 mg/kg 0/3 (m) 11 January 2001

Clinical signs:

Clinical signs of systemic toxicity were not evident.

Body weight:

No adverse effects on body weight.

Gross pathology:

Necropsy of each animal at the end of the 14-day post treatment observation period did not reveal any macroscopic pathology findings.

Any other information on results incl. tables

As outlined in the „Validity Assessment Report“ for the read-across approach (see IUCLID Section 13) read-across from testing data obtained with the UVCB substance WS400128 is considered appropriate for the safety evaluation as well as classification and labelling of the UVCB substance WS400136 based on the close chemical similarity between the two substances.

Applicant's summary and conclusion

Interpretation of results:

not classified

Remarks:

Migrated information no mortality at the limit dose of 2000 mg/kg Criteria used for interpretation of results: EU

Executive summary:

As outlined in the „Validity Assessment Report“ for the read-across approach (see IUCLID Section 13) read-across from testing data obtained with the UVCB substance WS400128 is considered appropriate for the safety evaluation as well as classification and labelling of the UVCB substance WS400136 based on the close chemical similarity between the two substances.

WS400136 does not necessitate any classification regarding acute oral toxicity.